399 related articles for article (PubMed ID: 19120904)
1. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S234-6. PubMed ID: 19120904
[TBL] [Abstract][Full Text] [Related]
2. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
Nema H; Kato M
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
[TBL] [Abstract][Full Text] [Related]
3. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
[TBL] [Abstract][Full Text] [Related]
4. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
5. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of gastroduodenal mucosal injuries in aspirin users.
Thongbai T
J Med Assoc Thai; 2013 Nov; 96(11):1423-7. PubMed ID: 24428091
[TBL] [Abstract][Full Text] [Related]
7. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.
Stoltz RR; Harris SI; Kuss ME; LeComte D; Talwalker S; Dhadda S; Hubbard RC
Am J Gastroenterol; 2002 Jan; 97(1):65-71. PubMed ID: 11808971
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
10. Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
Kordecki H; Kurowski M; Kosik R; Pilecka D
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():85-91. PubMed ID: 9440059
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study.
Tamura A; Murakami K; Kadota J;
QJM; 2011 Feb; 104(2):133-9. PubMed ID: 20870780
[TBL] [Abstract][Full Text] [Related]
12. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
Iijima K; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
[TBL] [Abstract][Full Text] [Related]
13. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
Lanza FL; Evans DG; Graham DY
Am J Gastroenterol; 1991 Jun; 86(6):735-7. PubMed ID: 2038996
[TBL] [Abstract][Full Text] [Related]
14. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
Aabakken L
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
[TBL] [Abstract][Full Text] [Related]
15. Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction.
Bar Dayan Y; Amital H; Levy Y; Shoenfeld Y
Isr J Med Sci; 1996 May; 32(5):288-91. PubMed ID: 8641865
[TBL] [Abstract][Full Text] [Related]
16. Does concomitant use of paracetamol potentiate the gastroduodenal mucosal injury associated with aspirin? A prospective, randomised, pilot study.
Boike JR; Kao R; Meyer D; Markle B; Rosenberg J; Niebruegge J; Stein AC; Berkes J; Goldstein JL
Aliment Pharmacol Ther; 2012 Aug; 36(4):391-7. PubMed ID: 22742578
[TBL] [Abstract][Full Text] [Related]
17. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
Goldstein JL; Scheiman JM; Fort JG; Whellan DJ
J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280
[TBL] [Abstract][Full Text] [Related]
18. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
Uemura N; Sugano K; Hiraishi H; Shimada K; Goto S; Uchiyama S; Okada Y; Origasa H; Ikeda Y;
J Gastroenterol; 2014 May; 49(5):814-24. PubMed ID: 23754512
[TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial.
Cryer B; Bhatt DL; Lanza FL; Dong JF; Lichtenberger LM; Marathi UK
Am J Gastroenterol; 2011 Feb; 106(2):272-7. PubMed ID: 21081908
[TBL] [Abstract][Full Text] [Related]
20. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission.
Mose H; Larsen M; Riis A; Johnsen SP; Thomsen RW; Sørensen HT
Am J Geriatr Pharmacother; 2006 Sep; 4(3):244-50. PubMed ID: 17062325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
